- Home
- WABC vs ALVO Comparison
WABC vs ALVO Comparison
Compare WABC & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WABC | ALVO |
|---|---|---|
| Founded | 1972 | 2013 |
| Country | United States | Luxembourg |
| Employees | 627 | 1460 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | WABC | ALVO |
|---|---|---|
| Price | $58.84 | $3.70 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $54.00 | $8.00 |
| AVG Volume (30 Days) | 175.0K | ★ 1.1M |
| Earning Date | 04-16-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.35% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.40 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.28 |
| Revenue Next Year | N/A | $18.63 |
| P/E Ratio | ★ $17.10 | $18.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $44.93 | $2.94 |
| 52 Week High | $59.25 | $9.94 |
Technical Indicators
Market Signals| Indicator | WABC | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 71.76 | 49.22 |
| Support Level | $46.94 | $3.65 |
| Resistance Level | N/A | $3.83 |
| Average True Range (ATR) | 1.25 | 0.32 |
| MACD | 0.12 | -0.02 |
| Stochastic Oscillator | 91.45 | 45.76 |
Price Performance
Historical ComparisonAbout WABC Westamerica Bancorporation
Westamerica Bancorp provides a full range of banking services to individual and commercial customers in Northern and Central California through its subsidiary bank. The Bank is a California-chartered commercial bank whose deposits are insured by the Federal Deposit Insurance Corporation (the FDIC) up to applicable limits. The principal communities served are located in Northern and Central California, from Mendocino, Lake and Nevada Counties in the north to Kern County in the south. The Company's strategic focus is on the banking needs of small businesses.
About ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.